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Abstract
Background: Human pluripotent stem cells (hPSCs) provide a promising cell source for ocular cell replacement therapy,
but often lack standardized and xenogeneic-free culture and differentiation protocols. We aimed to develop a xeno- and
feeder cell-free culture system for undifferentiated hPSCs along with efficient methods to derive ocular therapy target
cells: retinal pigment epithelial (RPE) cells and corneal limbal epithelial stem cells (LESCs).
Methods: Multiple genetically distinct hPSC lines were adapted to a defined, xeno-, and feeder-free culture system of
Essential 8™ medium and laminin-521 matrix. Thereafter, two-stage differentiation methods toward ocular epithelial cells
were established utilizing xeno-free media and a combination of extracellular matrix proteins. Both differentiation
methods shared the same basal elements, using only minor inductive modifications during early differentiation
towards desired cell lineages. The resulting RPE cells and LESCs were characterized after several independent
differentiation experiments and recovery after xeno-free cryopreservation.
Results: The defined, xeno-, and feeder-free culture system provided a robust means to generate high-quality hPSCs
with chromosomal stability limited to early passages. Inductive cues introduced during the first week of differentiation
had a substantial effect on lineage specification, cell survival, and even mature RPE properties. Derivative RPE formed
functional epithelial monolayers with mature tight junctions and expression of RPE genes and proteins, as well as
phagocytosis and key growth factor secretion capacity after 9 weeks of maturation on inserts. Efficient LESC
differentiation led to cell populations expressing LESC markers such as p40/p63α by day 24. Finally, we established
xeno-free cryobanking protocols for pluripotent hPSCs, hPSC-RPE cells, and hPSC-LESCs, and demonstrated successful
recovery after thawing.
Conclusions: We propose methods for efficient and scalable, directed differentiation of high-quality RPE cells and LESCs.
The two clinically relevant cell types are generated with simple inductive modification of the same basal method,
followed by adherent culture, passaging, and cryobanking.
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Background
The eye contains highly specialized cell types essential
for vision. Two cell types are particularly important for
maintaining ocular functions: corneal limbal epithelial
stem cells (LESCs) and retinal pigment epithelial (RPE)
cells. LESCs are the stem cell population located in
limbal niches at the corneoscleral junction, responsible
for the constant renewal of the stratified corneal epithe-
lium [1, 2]. The RPE is a pigmented monolayer located
beneath the neural retina, forming the outer blood-
retinal barrier (BRB) and maintaining the photoreceptors
via light absorption, phagocytosis, solute transport, and
growth factor secretion [3].
Significant loss or dysfunction of either LESCs or the
RPE can cause devastating, blinding diseases. RPE cell
death at the macula leads to loss of photoreceptor
function and results in age-related macular degeneration
(AMD), the leading cause of irreversible vision loss in
the elderly in industrialized countries [4]. Similarly,
diseases affecting the cornea are one of the leading
causes of vision loss worldwide. The most severe type of
corneal blindness is limbal stem cell deficiency (LSCD),
where the limbus is destroyed by acute trauma, or
chronic or genetic disease [5, 6]. Insufficiency of viable
LESCs results in conjunctivalization and opacification of
the corneal surface, and consequently loss of vision [7].
Such severe retinal and corneal diseases are difficult to
treat, but cell replacement therapy is proving to be a
viable strategy [8–10].
Human pluripotent stem cells (hPSCs) possess the
widest differentiation potential of all stem cell types,
providing endless possibilities for ocular cell replacement
therapies and personalized medicine. Human embryonic
stem cell (hESC) and human induced pluripotent stem
cell (hiPSC)-derived RPE are already being tested in
clinical trials to treat retinal degeneration [11, 12], and
LSCD is a promising target for the next hPSC-based
transplantation trials [13]. In the embryo, retina develops
from neuroectoderm via the optic vesicle, while corneal
epithelium derives from surface ectoderm [14] (Fig. 1a). In
the absence of inductive cues, hPSCs spontaneously follow
the neuroectodermal pathway, with a subset of cells
differentiating to RPE [15]. Alternatively, sequential
addition of growth factors, vitamins, and survival factors
Fig. 1 Schematic illustration of in vivo development and in vitro differentiation of RPE and LESCs. a At early stages of embryonic eye development,
surface ectoderm thickens and invaginates together with the underlying neuroepithelium of the optic vesicle. The bilayered optic cup gives rise to the
neural retina and the retinal pigment epithelium (RPE), while the lens and corneal epithelium develop from the surface ectoderm [14]. Some of the
known signaling pathways affecting the cell fate choice during differentiation, such as bone morphogenetic protein (BMP) for surface ectoderm, are
shown. b An overview of the optimized human pluripotent stem cell (hPSC) culture and directed RPE and limbal epithelial stem cell (LESC)
differentiation protocols, as well as key media and matrix components used (not to scale). Blebb. blebbistatin, col IV collagen type IV, E8 Essential 8™
Flex Medium, FGF fibroblast growth factor, LN-521 recombinant laminin-521, SB SB-505124 hydrochloride hydrate, TGFβ transforming growth factor
beta, XF-Ko-SR Knock-out™ serum replacement XenoFree CTS™
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can direct hPSC differentiation towards RPE or LESC
lineage [16–23]. Although many protocols have been
established, they are often complex, require cell line-
specific modifications, and include feeder cells or animal-
derived components at some stage of hPSC culture or
differentiation. Recently, strict regulatory demands and
efforts toward safer cell therapy products have prompted
the search for more standardized and xenogeneic-free
culture and differentiation protocols. In response, some
xeno-free protocols for RPE differentiation [24–28],
retinal organoid culture [29], and corneal epithelial
progenitor cell differentiation [30] have been introduced
within the past 2 years. However, they tend to be complex
and difficult to standardize across cell lines and laborator-
ies. In this study, we aimed to set up a feeder-free, xeno-
free culture method for hPSCs, and thereafter differenti-
ation, passaging, and cryostoring protocols to obtain pure
populations of high-quality RPE and LESCs. We show that
a minor switch in molecular cues during early hPSC
differentiation has a clear effect on the characteristics of
mature RPE and on the fate choice and cell survival
during LESC differentiation. Two versions of the same
basal method enabled large-scale production of pure
populations of high-quality RPE and LESCs that can be
serially passaged and cryostored to be readily available for
cell replacement therapies.
Methods
Pluripotent stem cell lines
The hESC lines Regea08/017 and Regea14/010 were derived
in-house, and both characterized similarly to Regea08/017
as described in [31]. The hiPSC lines (UTA.04311.WT,
UTA.04511.WT, UTA.04607.WT, UTA.10902.EURCCs,
and UTA.10802.EURCCs) were derived and characterized
at Prof. Katriina Aalto-Setälä’s laboratory at the University
of Tampere as previously described for cell lines
UTA.04311.WT and UTA.04511.WT [32, 33]. The hiPSC
line Hel24.3 was derived and characterized at Prof. Timo
Otonkoski’s laboratory at the University of Helsinki [34].
Pluripotent stem cell culture
Standard hPSC culture was carried out on human foreskin
fibroblast (hFF) feeder cells in hESC culture medium
containing 20% KnockOut™ Serum Replacement (Ko-SR;
Gibco, Thermo Fisher Scientific) as described previously
[31]. For feeder-free culture, hPSCs were transferred onto
well plates coated with 1.09 μg/cm2 human recombinant
laminin-521 (LN-521; Biolamina, Sweden) and cultured in
Essential 8™ Flex Medium (E8; Thermo Fisher Scientific)
supplemented with 50 U/ml penicillin-streptomycin
(Gibco, Thermo Fisher Scientific). Single cell passaging
with xeno-free TrypLE™ Select Enzyme (Gibco, Thermo
Fisher Scientific) was carried out twice a week onto
0.55 μg/cm2 LN-521, using a plating density of 40,000–
50,000 cells/cm2. A detailed description of hPSC culture
and characterization can be found in Additional file 1
(Supplementary Materials and Methods).
Ocular epithelial differentiation
RPE and LESC differentiation protocols are schematically
summarized in Fig. 1b. Undifferentiated hPSCs were
detached and transferred to Corning® Costar® Ultra-Low
attachment plates in XF-Ko-SR medium (KnockOut™
Dulbecoo’s modified Eagle’s medium (DMEM) supple-
mented with 15% KnockOut™ SR XenoFree CTS™ (XF-
Ko-SR), 2 mM GlutaMAX™, 0.1 mM 2-mercaptoethanol,
1% MEM non-essential amino acids, and 50 U/ml
penicillin-streptomycin (all from Gibco, Thermo Fisher
Scientific)) supplemented with 5 μM or 10 μM blebbista-
tin (Sigma-Aldrich) or Rock inhibitor Y-27632 dihy-
drochloride (ROCKi; R&D Systems) to induce embryoid
body (EB) formation overnight at +37 °C.
For RPE differentiation, EBs were either allowed to
undergo spontaneous differentiation in 15% XF-Ko-SR
medium, or were subjected to neuroectodermal induction
with 10 μM SB-505124 (Sigma-Aldrich) and 10 μM IWP-
2 (Merck Millipore). During the 4–6 day induction period
the medium was changed daily, after which the EBs were
transferred onto well plates coated with 0.75 μg/cm2
LN-521 and 10 μg/cm2 human placental collagen type IV
(col IV; Sigma-Aldrich) in 15% XF-Ko-SR medium. The
medium was thereafter changed three times a week.
Pigmented foci were manually separated with a scalpel,
dissociated with TrypLE™ Select Enzyme, and the resulting
singe-cell suspension replated to culture wells coated with
LN-521 and col IV. For further passaging, the RPE cells
were detached with TrypLE™ Select Enzyme. For the final
passage, the RPE cells were plated to similarly coated
polyethylene terephthalate (PET) hanging cell culture
inserts with a 1.0 μm pore size (Merck Millipore).
For LESC differentiation, EBs were subjected to
surface ectodermal induction: 1 day in XF-Ko-SR
medium supplemented with 10 μM SB-505124 and
50 ng/ml human basic fibroblast growth factor (bFGF;
PeproTech Inc., Rocky Hill, NJ, USA), followed by
2 days in XF-Ko-SR medium supplemented with
25 ng/ml bone morphogenetic protein (BMP)-4
(PeproTech Inc.). Thereafter, the EBs were transferred
onto well plates coated with 0.75 μg/cm2 LN-521 and
5 μg/cm2 col IV in a defined and serum-free medium
CnT-30 (CELLnTEC Advanced Cell Systems AG,
Bern, Switzerland) at a density of approximately 15
EBs per cm2. The cells were thereafter maintained in
CnT-30, changing the medium three times a week. A
detailed description of ocular epithelial differentiation
methods can be found in Additional file 1 (Supple-
mentary Materials and Methods).
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Characterization of hPSC-RPE cells
The hPSC-RPE cells were characterized after 9 weeks of
maturation on PET cell culture inserts. RPE-specific
gene expression was assessed with reverse transcription
polymerase chain reaction (RT-PCR), and key RPE
protein expression and localization was verified with
immunofluorescence labeling as previously described
[35]. Images were captured with an LSM 700 Confocal
microscope (Carl Zeiss, Jena, Germany) using a 40×
objective or 63× oil immersion objective. Retinal
pigment epithelium-specific 65 kDa protein (RPE65) and
Bestrophin (BEST) protein expression levels were
studied with Western blotting as previously described
[36]. Pigmentation intensity and RPE cell size were
quantified with ImageJ Image Processing and Analysis
software (https://imagej.nih.gov/ij/) tools. Transepithelial
electrical resistance (TEER) was measured with a
Millicell electrical resistance system volt-ohm meter
(Merck Millipore). Enzyme-linked immunosorbent assay
(ELISA) for pigment epithelium-derived factor (PEDF)
secretion was carried out with the Human PEDF ELISA
kit (BioVendor, Brno, Czech Republic) from apical media
collected after 19 h incubation and analyzed at 300×
dilution according to the manufacturer’s instructions.
Phagocytosis assay was conducted with porcine
photoreceptor outer segments (POS) by 4 h apical
feeding at +37 °C (or at +4 °C for negative controls) in
the presence of 10% fetal bovine serum (FBS; Gibco,
Thermo Fisher Scientific), followed by labeling with anti-
opsin antibody and phalloidin-tetramethylrhodamine B
isothiocyanate. Z-stack images were acquired with a con-
focal microscope to visualize internalized POS. Details of
characterization assays and antibodies can be found in
Additional file 1 (Supplementary Materials and Methods).
Characterization of hPSC-LESCs
Gene expression during early corneal differentiation
was assessed with quantitative PCR (qPCR) analysis
as previously described [21]. The hPSC-LESCs were
characterized after 22–25 days of differentiation, and
after recovery from cryopreservation (total differenti-
ation time 26/28 and 34 days). Immunofluorescence
labeling of hPSC-LESCs was performed as previously
described [21]. The protein expression of p40, p63α,
and paired box protein Pax-6 (PAX6) was quantified
either from double-stained cytospin samples or from
cell samples double-stained directly in the culture
vessels. For cell counting, 10 randomly selected
images were captured with 10× magnification from
two separate samples. For each image, ImageJ soft-
ware was used to count nuclei positive for p40, p63α,
and/or PAX6, and positive expression relative to total
cell number (4',6-diamidino-2-phenylindole (DAPI)
stained nuclei) was calculated. Maturation of hPSC-
LESCs to a stratified corneal epithelium was induced
in vitro with calcium chloride supplementation as
well as airlifting and indirect co-culture with 3 T3
mouse embryonic fibroblasts. The cells were visual-
ized with confocal imaging after immunofluorescence
labeling. Details of characterization assays and antibodies
can be found in Additional file 1 (Supplementary
Materials and Methods).
Cryopreservation of hPSCs, hPSC-RPE cells, and hPSC-
LESCs
Undifferentiated hPSCs were cryostored with pre-
chilled PSC Cryopreservation Medium according to
the manufacturer’s instructions, and RevitaCell™
Supplement (both from Thermo Fisher Scientific) was
used for 24 h to facilitate post-thaw recovery. Early
passage cells (up to feeder-free passage level 5) were
detached, counted and cryostored as a single cell
suspension in 1 ml aliquots of ready-to-use, xeno-free
PSC Cryopreservation Medium. Cells in CryoPure tubes
(Sarstedt) were placed at –80 °C in a CoolCell™ LX
Freezing Container (Sigma-Aldrich) overnight, and there-
after transferred to liquid nitrogen for long-term storage.
Cell were thawed quickly at room temperature, suspended
to pre-warmed media, centrifuged, and resuspended again
to fresh, pre-warmed media for plating.
Human PSC-RPE cells were cryopreserved in 40%
XF-Ko-SR and 10% dimethyl sulfoxide (DMSO;
Sigma-Aldrich) in XF-Ko-SR medium. Cells were
cryopreserved in exponential growth phase 7–14 days
after passaging at either RPE passage level one or
two. Human PSC-LESCs were cryopreserved in 40%
XF-Ko-SR and 10% DMSO in CnT-30 medium. Cells
were cryopreserved and thawed as single cells
suspension to their respective media, as described
above for hPSCs. For hPSC-RPE, higher concentra-
tions (1.8 μg/cm2 LN-521 and 10 μg/cm2 col IV) of
extracellular matrix (ECM) coatings on PET inserts
were used for recovery after cryostorage.
Results
We aimed to establish a xeno-free and feeder-free
culture method for hPSC maintenance and efficient
differentiation to clinically relevant RPE cells and
LESCs. This was achieved by mimicking early ocular
development with small molecule induction towards
desired cell lineages, followed by culture in XF-Ko-SR
medium or CnT-30 medium. Importantly, a combin-
ation of LN-521 and col IV supported attachment,
growth, and differentiation of both RPE and LESCs.
An overview of the in vitro differentiation protocols
is shown in Fig. 1b.
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LN-521 matrix in combination with E8™ medium provides
a robust, xeno- and feeder-free hPSC culture system for
short-term maintenance
A xeno-free, feeder-free hPSC culture system was set up
using human recombinant LN-521 as an attachment
matrix and E8™ as the medium. Eight individually
derived, genetically independent hPSC lines (two hESC
and six hiPSC lines) were transferred from culture on
hFF feeder cells to feeder-free conditions (Table 1),
adopting single cell passaging after the first 1 to 2
passages. Variation in capacity to adapt to the new
culture system was evident between cell lines. Maximum
passages in undifferentiated culture achieved for each
cell line are shown in Table 1, along with the passages
used for RPE and LESC differentiation.
The hPSCs grew as homogeneous monolayers with
typical morphology and expression of pluripotency
markers, as shown for hESC1 in Fig. 2. Comparison with
hPSCs cultured on hFF feeder cells showed higher
expression of stage-specific embryonic antigen (SSEA)-4
and octamer-binding transcription factor (OCT)-3/4
pluripotency markers in the feeder-free culture system
(Fig. 2c). Feeder-free hPSCs were capable of spontaneous
differentiation to all three embryonic germ lineages, and
retained a stable karyotype at early passages (Fig. 2d and
e). Characterization data for hiPSC1 and hiPSC2 are
shown in Additional file 2 (Figure S1) and Additional file
3 (Figure S2), respectively. Cryostocks in xeno-free
cryomedium were prepared at early passages (up to
passage level 5) for each cell line and cell recovery was
successful after several weeks of cryostorage.
In addition, hPSC culture was attempted in NutriS-
tem® hPSC XF Medium combined with LN-521 matrix,
but neither the hESC2 line nor the hiPSC4 line were
able to grow beyond the fourth passage. E8 was also
tested in combination with truncated human recombin-
ant vitronectin (VTN-N) matrix, weekly passaging
hPSCs as cell clusters with EDTA as recommended by
the manufacturer. This culture system enabled undiffer-
entiated pluripotent culture of hESC1 for 23 passages
(with normal karyotype at passage 15) and hiPSC3 for
15 passages (Additional file 4: Figure S3). However,
cluster passaging on VTN-N led to varying split ratios
and passaging intervals, making the protocol user-
sensitive, more laborious, and difficult to standardize. In
contrast to colony culture on VTN-N, single cell passa-
ging on LN-521 matrix allowed for cell counting and
consistent plating densities around 50,000 cells/cm2,
guaranteeing standardized and efficient cell production.
In addition, passaging twice a week allowed for a
weekend-free feeding regimen. Our post-hoc cell count-
ing showed that, in practice, within each passage the
hESC1 populations multiplied on average 3.44-fold (SD
1.71, n = 24 in feeder-free passages 3–12) and hiPSC2
multiplied on average 2.89-fold (SD 0.77, n = 11 in
feeder-free passages 3–9) (Additional file 5: Table S1).
Karyotypic changes at the 20q arm occurred in hESC1
after 25 passages and in hiPSC3 after 23 passages in the
LN-521 and E8 culture system. The karyotypically
abnormal cells acquired a growth and differentiation
advantage to RPE and the cultures were thus aborted.
However, long-term, feeder-free culture of hESC1 was
also carried out with a normal karyotype up to passage
27. In order to avoid chromosomal changes, hPSCs were
thereafter cultured for a maximum of 15 passages in
feeder-free conditions and only low passage cells were
used for differentiation.
Two-stage xeno-free differentiation yielded functional
hPSC-RPE, with early neuroectodermal induction increasing
pigmentation
After setting up and optimizing the feeder-free hPSC
culture protocol, a RPE differentiation strategy was
established with two representative hPSC lines (hESC1
and hiPSC1). Several approaches were tested to achieve
a functional protocol (Additional file 6: Supplementary
Table 1 Cell lines and maximum passages for feeder-free hPSC culture and subsequent RPE and LESC differentiations
Cell line (hESC/hiPSC) Maximum FF passage Cell line (hESC/hiPSC) FF passages for RPE differentiation
Regea08/017 (hESC1) 28
(31 (p25: 46;XX 20q tel*))
Regea08/017 (hESC1) 5, 8, 10, 22, 24
Regea14/010 (hESC2) 11 UTA.10902.EURCCs (hiPSC1) 5, 7
UTA.10902.EURCCs (hiPSC1) 10
UTA.04607.WT (hiPSC2) 15
UTA.04511.WT (hiPSC3) 29 (p23: 46;XY 20q11**) Cell line (hESC/hiPSC) FF passages for LESC differentiation
Hel24.3 (hiPSC4) 19 Regea08/017 (hESC1) 6, 6, 8
UTA.10802.EURCCs (hiPSC5) 4 UTA.04607.WT (hiPSC2) 3, 6, 13
UTA.04311.WT (hiPSC6) 11
*Changes at the q telomere of chromosome 20
**Translocation at 20q11
FF feeder-free, hESC human embryonic stem cell, hiPSC human induced pluripotent stem cell, LESC limbal epithelial stem cell, p passage, RPE retinal
pigment epithelium
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Fig. 2 (See legend on next page.)
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Dataset 1). Two-stage differentiation in 15% XF-Ko-SR
medium, initiated in suspension (day 0–5), followed by
adherent culture that was finalized on cell culture
inserts, yielded mature RPE within a total of 19 weeks
(Fig. 3a). Blebbistatin or ROCKi were required for viable
EB formation, and a combination of LN-521 and col IV
allowed for optimal attachment and RPE maturation. A
4-day neuroectodermal induction with the Wnt inhibitor
IWP-2 and the transforming growth factor (TGF)-β
inhibitor SB-505124 during the EB stage was used to
direct differentiation. This neuroectodermal induction
significantly (p < 0.01) increased the degree of pigmenta-
tion of the mature RPE layer (Fig. 3b and c) in a cell
line-independent manner and repeatedly throughout
seven separate differentiation experiments (five with
hESC1 and two with hiPSC1). Spontaneous differenti-
ation yielded smaller and more lightly pigmented RPE
cells with a smoother epithelial morphology and signifi-
cantly higher (p < 0.01) TEER values (Fig. 3d). The
higher TEER indicates tight junction integrity and an
intact epithelial barrier function. Moreover, zonula
occludens-1 (ZO-1) and Claudin-19 (Cl-19) localization
at junctional complexes indicated mature tight junctions,
and their expression was similarly detected in cells
differentiated with and without neuroectodermal
induction (Fig. 3e). Confocal stacks of tight junction
protein labeling confirmed monolayer structures.
Despite the differences in pigmentation and TEER, cells
differentiated with and without neuroectodermal induc-
tion expressed the RPE-specific genes RPE65, BEST,
tyrosinase (TYR) and melanocyte protein PMEL, while
lacking expression of the pluripotency marker OCT-4
(Fig. 4a). They expressed visual cycle proteins RPE65
and cellular retinaldehyde binding protein (CRALBP), as
well as the transporter proteins bestrophin and apically
localized sodium-potassium adenosine triphosphatase
(Na+K+-ATPase) (Fig. 4b and C). Furthermore, the cells
showed correct RPE functionality by phagocytosis of
porcine POS and apical secretion of high concentrations
of PEDF (Fig. 4d and e). Finally, RPE cells differentiated
with and without neuroectodermal induction showed
normal karyotypes after 9 weeks of final maturation on
cell culture inserts (data not shown). The characterization
of hiPSC-RPE is shown in Additional file 7 (Figure S4).
Overall, high-quality, functional RPE was derived using a
completely xeno-free differentiation method from xeno-
and feeder-free starting material, with 4-day neuroectoder-
mal induction increasing the level of pigmentation of
mature epithelial cell layers.
Fine-tuning the early small molecule induction during
two-stage, xeno-free differentiation guided hPSCs toward
surface ectoderm and corneal LESC fate
Next, we established a differentiation protocol to derive
LESCs from two xeno- and feeder-free hPSC lines
(hESC1 and hiPSC2). The same platform of 15% XF-Ko-
SR-containing medium and the LN-521 and col IV com-
bination matrix served as a starting point, and blebbista-
tin was used to promote aggregation and cell survival
during EB formation. Our previously published protocol
based on blocking TGF-β and Wnt signaling and activat-
ing FGF signaling, was established using hPSCs main-
tained on hFF feeder cells, and resulted in excessive cell
death or neuronal differentiation of feeder-free hPSCs.
Several strategies and modifications were tested to over-
come this issue (see Additional file 8: Supplementary
Dataset 2 and Additional file 9: Figure S5). Adding a
mesodermal BMP4 induction after a short ectodermal
induction directed differentiation toward surface ecto-
derm and corneal fate. Two-day induction with BMP4
after an overnight ectodermal induction with SB-505124
and bFGF, followed by adherent culture on LN-521 and
col IV combination matrix in Cnt-30 epithelial medium,
led to efficient differentiation of LESC-like epithelial
cells (Fig. 5a). Already after 22 days of differentiation,
the cells showed epithelial morphology (Fig. 5b), and
expressed acknowledged LESC markers p40, p63α, and
PAX6. Putative LESC markers cytokeratin-15 (CK15)
and cytokeratin-14 (CK14) were also expressed in part,
but mature corneal cytokeratins-12 (CK12) and -3 (CK3)
were undetected at this stage (Fig. 5c). We observed a
similar expression pattern using hiPSC (shown for
hiPSC2-LESCs in Additional file 10: Figure S6). Cell
counting confirmed 72% of the cells as p40 positive and
71% as p63α positive (and 64% double-positive for p40
and p63α) as early as day 24 of differentiation (Fig. 5d).
(See figure on previous page.)
Fig. 2 Essential hPSC characteristics were maintained throughout culture on recombinant laminin-521 (LN-521) in Essential 8™ Flex Medium (E8),
shown for hESC1. a Typical undifferentiated colony morphology the day after passaging (upper picture, scale bar = 50 μm) and a higher magnification
of the cells at confluency prior to the next passaging (day 4, lower picture, scale bar= 20 μm). Cells at feeder-free passage level 4, passage 40 in total. b
Expression of pluripotency markers NANOG, OCT-3/4, SSEA-3, SSEA-4, TRA-1-60, and TRA-1-81, and no expression of early differentiation marker SSEA-1,
at passages 8–13. Nuclei counterstained with DAPI; scale bars= 200 μm. c Flow cytometry analysis of human embryonic stem cells (hESCs) cultured in
feeder-free conditions compared to hESCs cultured on hFF feeder cells in standard hESC medium. Blue histogram for positive, black for negative
(unstained) sample, and red for isotype control. d Expression of markers of the three embryonic germ layers after spontaneous differentiation. Nuclei
counterstained with DAPI; scale bars = 200 μm. e Cells after 25 passages showing normal female karyotype in KaryoLite BoBs assay. The results are
shown as signal relative to karyotypically normal female (/F, red) and male (/M, blue) genomic DNA used as a reference (equal to 1) for each of the 24
chromosomal probes (cover both p and q arms of all chromosomes). Software threshold for changes shown as a green line and deviating results in red
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Cryopreservation and successful recovery of hPSC-RPE
cells and hPSC-LESCs enables generation of readily available
cell products
Cryobanking and recovery protocols for hPSC-derived
RPE and LESCs were established using 40% XF-Ko-SR
to buffer 10% DMSO medium, and cells were success-
fully recovered onto a LN-521 and col IV combination
matrix. For hPSC-RPE, passaging was required to
achieve an exponential growth phase for cryopreserva-
tion. The optimal window for cryostorage was 5–14 days
after passaging, as RPE was changing morphology from
fibroblastic to epithelial. The cryostoring was performed
either after selection and plating (RPE passage level p1)
or after additional replating to purify the RPE population
Fig. 3 A xeno-free, feeder-free differentiation strategy led to efficient production of high-quality retinal pigment epithelial (RPE) cells. a Schematic
illustration of the RPE differentiation pipeline. b Images of pigmented patches after 35 days of differentiation (upper row; scale bars= 1 cm) with and
without initial neuroectodermal induction (+/– ind.) for hESC1-RPE. Images of cell culture inserts (middle row; scale bar= 6.5 mm) and DIC confocal images
(lower row; scale bars= 10 μm) after 9 weeks of final maturation on inserts, illustrating the difference in pigmentation. c Quantification of pigmentation
using image analysis after 9 weeks on inserts presented as mean pixel intensity relative to spontaneous differentiation (– ind.; n= images from two
individual differentiation experiments), and (d) quantification of cell size after 9 weeks on inserts presented as mean cell area (μm2; n= number of cells
examined). e Mean TEER values after 9 weeks on inserts, differentiated with or without induction (n= inserts analyzed from four individual differentiation
experiments). f Phalloidin labeling for filamentous actin and vertical confocal sections of junctional proteins zonula occludens-1 (ZO-1) and Claudin-19 (Cl-
19). Scale bars= 20 μm. Error bars denote standard deviation. Mann–Whitney U test was used for assessing statistical significance; ***p< 0.01. Blebb.
blebbistatin, EB embryoid body
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(RPE passage level p2). Although we did not aim for
maximal production speed or quantity, in practice we
were able to cryostore an average of 2.2 × 106 hESC1-
RPE cells from 1.0 × 106 pluripotent hESC1 cells in
64–84 days without induction (SD 2.3, n = 4 differenti-
ation experiments), producing at best 5.6 × 106 RPE from
1.0 × 106 pluripotent hESC1 cells in 63 days. With
induction we have been able to cryostore 1.04 × 106 RPE
cells from 1.0 × 106 hESC1 cells as fast as in 42 days.
After freezing at RPE p1, the cells required an additional
passage for purification, allowing further expansion,
while if frozen at RPE p2, the cells were directly thawed
to cell culture inserts for final analysis. After recovery,
hESC1 RPE cells were maintained on cell culture inserts
for 10 weeks. They showed lower TEER compared to
cells that had not gone through a cryopreservation step
(Fig. 6a) but preserved their RPE marker expression
status (Fig. 6b).
Human PSC-LESCs were cryostored at day 22–25 of
differentiation when correct morphology and marker
expression were detected. On average 0.72 × 106 hESC1-
LESC cells were produced for cryostorage from 1 × 106
feeder-free hESC1 cells (SD 0.54, n = 6 differentiation
experiments) by day 23 of differentiation. Human PSC-
LESCs possessed appropriate epithelial morphology and
LESC marker expression directly after recovery (4 days
post-thawing, day 24–28 in total), and also after
additional replating for expansion (day 34 in total)
(Fig. 6c and Additional file 10: Figure S6). Over 80% of
the cells expressed p40 and over 90% expressed PAX6
after cryostorage (Fig. 6d), suggesting that cryostoring
and replating steps helped to purify the hPSC-LESC
population even further. Moreover, the cells showed the
capacity to form a stratified epithelium with apical tight
junctions and expression of CK3 (Fig. 6e) as well as a
p40-expressing stem cell population at the basal layer
(Fig. 6f ). Overall, successful cryopreservation protocols
were established for RPE and LESCs, enabling cell
banking that is essential for generation of future cell
therapy products.
Fig. 4 High-quality, functional RPE was obtained with the xeno-free differentiation method. a RT-PCR showing signature RPE gene expression,
and b immunofluorescence labeling and c Western blot showing key RPE protein expression after final maturation on inserts for hESC1-RPE. Nu-
clei counterstained with DAPI; scale bars = 20 μm. d Confocal sections after 4 h POS feeding at +37 °C and at +4 °C (negative control; neg.contr.).
Arrows indicate internalized POS labeled with anti-opsin antibody. Scale bars = 20 μm. e Mean PEDF secretion measured with ELISA from the
apical side of cell culture inserts; n = number of inserts from two independent differentiation experiments. Error bars denote standard deviation.
+/– ind. with and without induction, hPSC human pluripotent stem cell
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Discussion
Clinical safety of cell-based therapies requires the use of
highly defined and preferably xenogeneic-free techniques
with economically reasonable cost. In this study, we
developed simple but efficient methods for high-quality
hPSC culture and differentiation towards RPE and LESC
lineages. A minor modification of the inductive cues
during the first week of differentiation steered hPSCs
toward either the RPE or LESC fate, enabling production
of two clinically relevant ocular cell types with the same
basal method.
The culture of hPSCs has advanced from mouse or
human feeder cell-based systems to feeder-independent
culture on ECM proteins or their fragments in
chemically defined, xeno-free media such as NutriStem®
hESC XF medium (Biological Industries) and TeSR™2
medium [37]. The E8 medium was a major breakthrough
as an albumin-free, current Good Manufacturing Prac-
tice (cGMP)-compliant medium containing only eight
components essential for hPSC culture [38]. Consistent
with earlier studies, we were able to achieve efficient
monolayer culture of eight genetically distinct hESC and
hiPSC lines in E8 medium combined with LN-521
matrix [39–41]. We found that prolonged feeder-free
culture using single cell passaging led to karyotype
changes that generated growth and differentiation
advantages. In our analysis, two hPSC lines acquired
karyotypic changes in the 20q arm—a known hot spot
for chromosomal changes in hPSCs [42]. The gain of
20q11.21 allows hPSCs to escape apoptosis, allowing
abnormal cells to take over the culture [43]. Feeder-free
cultures thus require frequent karyotyping and use of
low-passage hPSCs for differentiation. The safe window
for usage is short; a maximum of 15 feeder-free passages
equals 7.5 weeks of culture, while we have routinely
cultured hPSCs on hFF feeders using manual passaging
for up to 100 weeks with stable karyotypes. However,
the feeder-free monolayer culture on LN-521 is more
Fig. 5 Directed differentiation of feeder-free hPSCs led to rapid hPSC-LESC production. a Schematic illustration of the differentiation strategy. b Phase-
contrast images showing cell morphology after 22 days of differentiation for hESC1-LESCs; scale bars= 100 μm. c Expression of LESC markers after
22 days of differentiation. Nuclei counterstained with DAPI; scale bars = 100 μm. d Percentage of p40- and p63α-positive cells quantified from cytospin
samples after 24 days of differentiation; n = 10 images, 1986 cells. bFGF basic fibroblast growth factor, Blebb. blebbistatin, BMP bone morphogenetic
protein, IF immunofluorescence, SB SB-505124 hydrochloride hydrate
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efficient, scalable, and less laborious compared to feeder-
based systems. In practice, an average of approximately
threefold cell multiplication pace was achieved within
each passage (3–4 days) during successful culture. This
means that a single 24-well of hPSCs (~100,000 cells)
can expand into ~2.7 × 106 cells within 3 passages
(1.5 weeks). This efficiency enables the use of low-
passage feeder-free hPSCs to produce clinically relevant
numbers of differentiated cell types. Minimized variability
due to culture medium and matrix simplicity, and flexi-
bility as a weekend-free feeding regimen, also add value
and decrease costs.
Besides the well-defined and high-quality hPSCs,
successful stem cell-based therapy requires differenti-
ation methods with sufficient yield and purity. Recently,
several hPSC differentiation strategies mimicking whole
eye development have been reported to generate
multiple ocular cell types in zones of two-dimensional
colonies [44], or complex three-dimensional corneal [13,
45] or retinal organoids [29]. Ocular organoids recapitu-
late the early developmental events in vitro and provide
powerful three-dimensional model systems for studying
developmental or disease processes. However, these pro-
tocols are complex and time-consuming, difficult to
Fig. 6 Human PSC-RPE and hPSC-LESCs maintained their cellular phenotypes after cryopreservation. a Human ESC1-RPE were cryopreserved for
52 days (–ind.) or for 281 days (+ind.) and thawed to 1.8 μg/cm2 LN-521 + 10 μg/cm2 col IV combination matrix. After 74 days (–ind.) and 71 days
(+ind.) of post-thaw culture on inserts the cells showed (a) mean TEER values of 217 and 151 *cm2 (n = 4 inserts and 6 inserts), (b) expression and
localization of zonula occludens-1 (ZO-1) and Claudin-19 (Cl-19) to tight junctions, expression of the visual cycle protein cellular retinaldehyde binding
prot (CRALBP), and apical expression of Na+K+ATPase and tyrosine-protein kinase Mer (MERTK); scale bars= 20 μm. c Human ESC1-LESCs, 4 days after
recovery from cryostocks (103 days frozen, day 28 of differentiation in total) maintained morphology and expression of LESC markers similar to fresh
cells; scale bars = 100 μm. A similar morphology and expression pattern was achieved after replating for expansion (day 34 in total). d Quantification of
p40 and PAX6 expression for both hESC-LESCs (hESC1) and hiPSC-LESCs (hiPSC2) confirmed that the high LESC marker expression was retained during
subsequent culture and replating after cryopreservation; n = 10 images, minimum of 2205 individual cells per time point. e After in vitro stratification
assay, hPSC-LESCs showed expression of ZO1 tight junction protein and CK3, indicating maturity. f Confocal stacks confirmed expression of p40 at the
basal layer of the stratified structure after 3 days of airlifting (shown for hiPSC2-LESCs). Scale bars= 20 μm. BF bright field
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standardize for production of high cell yields for cell
therapy applications, and would require rigorous sorting
of the desired cell populations [46].
Within the last 2 years, several research groups intro-
duced xeno-free protocols for spontaneous or directed
clinical grade RPE differentiation [24–27, 29]. In our
hands, attempts to replicate some of these methods were
unsuccessful. Plaza Reyes et al. used spontaneous RPE
differentiation in suspension in tailored NutriStem hESC
XF medium lacking bFGF, and further plating of
selected, pigmented RPE cells to LN-521 [25]. Our
attempts to achieve RPE differentiation in EB suspen-
sions led to disaggregation of EBs and insufficient levels
of pigmentation. On the other hand, differentiation in
X-VIVO™ 10 medium (Lonza), previously reported for
xeno-free RPE differentiation [24], led to extreme
pigmentation at the expense of RPE and epithelial
properties (Additional file 6: Supplementary Dataset 1).
RPE differentiation with XF-Ko-SR basal medium was
recently reported by Choudhary and co-workers as an
adherent monolayer-based method relying on temporal
and sequential dual SMAD inhibition, BMP4, and
Activin A activation [26]. Their approach was efficient
and fast, with RPE-specific genes upregulated in 40 days,
allowing whole plate passaging without the need for
manual selection of pigmented cells. However, they
found lower expression levels of key RPE genes in these
cells compared with spontaneously differentiated hPSC-
RPE. This again emphasizes the need for a prolonged
culture of several weeks followed by purification and
expansion to allow for proper RPE maturation. Our
approach of using the XF-Ko-SR, together with LN-521
and col IV combination matrix, was suitable for either
spontaneous or simple, directed, xeno-free RPE differen-
tiation producing high-quality RPE. We also demon-
strate that a similar method, with minor modifications,
yields corneal LESCs; the induction stage was performed
in XF-Ko-SR, and adherent culture was continued in
CnT-30, a commercially available, fully defined culture
medium developed for primary corneal epithelial cells.
In its current formulation, CnT-30 contains animal-
derived (but clinical grade) heparin, which could be
replaced for a fully xeno-free medium. Most previously
published studies to generate corneal epithelial cells
from hPSCs have relied on the use of undefined, xeno-
geneic factors such as conditioned medium, PA6 feeder
cells, Bowman’s, or amniotic membranes [16, 19, 47, 48].
A recent, defined protocol to differentiate a single hESC
line to corneal epithelial progenitor cells utilized simple
keratinocyte serum-free medium (KSFM) mixed with
DMEM/F12 for increased calcium concentration,
together with a simple col IV matrix [30]. ABCG2- and
p63-positive populations were produced in just 6 days
but differentiation required elevated CO2 levels. The
mechanism behind these differentiation conditions was
not discussed [30].
When directing feeder-free hPSC differentiation
towards ocular epithelial lineages, suspension culture as
EBs greatly improved cell survival, while small molecule
induction helped direct differentiation. For feeder-free
LESC differentiation, ectodermal induction alone was
insufficient, resulting in neural network formation or cell
death. A mesodermal induction with BMP4 was
beneficial in directing differentiation towards surface
ectoderm, and consequently LESCs. BMP4 is important
in anterior eye segment development, induces corneal
and epidermal differentiation, and inhibits neural
differentiation [49, 50]. In our study, this two-stage
surface ectodermal induction followed by adherent
culture on LN-521/col IV combination matrix in
CnT-30 medium resulted in > 70% p63α-positive cell
populations in 24 days. As for RPE, the TGF-β signaling
inhibitor SB-431542 has been previously shown to
enhance pigmentation rate during initial differentiation,
but in a cell line-dependent manner [51]. Meanwhile,
Wnt signaling induces RPE differentiation once the cells
are committed to the retinal fate [52, 53]. Our short
neuroectodermal induction with Wnt and TGF-β inhibi-
tors repeatedly increased pigmentation of mature RPE
layers in all seven experiments and with both cell lines.
The role of pigmentation resulting from melanin content
in the RPE remains somewhat speculative. The pigment
serves to store Ca2+, absorb stray light, and minimize
scatter within the eye, but melanosomes also act as
antioxidants, eliciting cytoprotective functions [54]. We
have previously shown the inverse relationship of TEER
and pigmentation [36], and continuously see this effect
with hPSC-derived RPE. The mechanism behind this
phenomenon and its clinical significance requires further
studies. It was recently shown that the level of pigmenta-
tion does not correlate with hPSC-RPE maturity,
although it is commonly used as such a marker [55].
Interestingly, highly pigmented hPSC-RPE appear to
have significantly higher expression of pathways related
to calcium signaling and adherens junction remodeling,
compared with lightly pigmented cells [55]. Pigmentation
may also affect other aspects of physiology and functional-
ity of the intact RPE monolayer, and its relevance for
transplantation success calls for further studies.
Ocular cell replacement therapies require relatively
small populations of RPE (1.3 × 3.0 mm patch or 0.2 ×
106 cells in suspension) [11, 12] or a few thousand
p63-bright LESCs [56] per eye, but quality assurance for
GMP compliance requires additional cell populations
and thus scale-up of culture and differentiation. RPE
differentiation from hPSCs tends to be time consuming,
so using fresh hPSC-RPE for cell replacement therapy
requires a long waiting time for the patient. In contrast,
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the hPSC-LESC differentiation period is too rapid to
allow for quality and safety testing prior to transplant-
ation. Cryobanking offers a solution by allowing prepar-
ation of readily available cell stocks in advance. A recent
study showed successful cryostoring and recovery of
xeno-free hiPSC-derived neuroretinal organoids, and
further isolated photoreceptor precursor cells, as well as
RPE cells [29]. With our xeno-free methods, a starting
culture of 1 × 106 feeder-free hPSCs can yield cryostocks
of > 5 × 106 RPE cells in 9 weeks, and nearly 1 × 106
LESCs within 23 days. Controlled passaging of hPSC-
RPE once or twice is essential to achieve purity and
successful cryostoring at the exponential growth phase,
while passaging more than three times changes the
hPSC-RPE phenotype [57]. Meanwhile, LESC purity
improved after cryostoring and passaging, as suggested
by ubiquitous p40 and p63α protein expression.
GMP-compliant derivation, culture, and differentiation
methods are a requisite for cell-based medicinal
products, including hPSC-derived cells [58]. Xeno-free,
GMP-quality, clinical-grade hPSC-RPE products such as
OpRegen® cells are emerging [28], but simplified proto-
cols and raw materials for cell culture and differentiation
are an advantage. The simple xeno-free methods
described here could be upgraded to GMP-quality for
future preclinical testing.
Conclusions
We provide a simple but efficient methodology to pro-
duce two clinically relevant ocular epithelial cell types
from feeder- and xeno-free hPSCs. Our results show that
the simple, cost-effective methods produce high-quality
RPE and LESCs from multiple cell lines and across
several differentiation experiments. The safety and
functional efficacy testing of the hPSC-RPE and hPSC-
LESCs produced with these protocols are currently
ongoing in non-human primates and rabbit models of
LSCD, respectively.
Additional files
Additional file 1: Supplementary materials and methods. (DOCX 65 kb)
Additional file 2: Figure S1. Human iPSC line hiPSC1 cultured on LN-
521 in E8 medium maintained pluripotent characteristics. A) Typical
undifferentiated morphology and B) expression of pluripotency markers
NANOG, OCT-3/4, SSEA-3, SSEA-4, TRA-1-60, and TRA-1-81, as well as
corresponding nuclear stains with DAPI after 4 passages in feeder-free
culture. C) Pluripotency shown as expression of markers of the three
embryonic germ layers, namely SOX17 for endoderm, OTX2 for ectoderm,
and SMA for mesoderm after spontaneous differentiation (feeder-free
passage level 4). All scale bars = 200 μm. D) Cells showing normal female
karyotype after nine passages. (TIF 5463 kb)
Additional file 3: Figure S2. Human iPSC line hiPSC2 cultured on LN-
521 in E8 medium maintained pluripotent characteristics. A) Typical
undifferentiated morphology and B) expression of pluripotency markers
OCT-3/4, SSEA-3, SSEA-4, TRA-1-60, and TRA-1-81, and LIN-28 as well as
corresponding nuclear stains with DAPI after 11 passages in feeder-free
culture. C) Pluripotency shown as expression of markers of the three
embryonic germ layers after spontaneous differentiation (feeder-free
passage level 8). All scale bars = 200 μm, except for SMA = 100 μm. D)
Cells showing normal female karyotype after nine passages. (TIF 5580 kb)
Additional file 4: Figure S3. Human ESC line hESC1 cultured on VTN-N
matrix in E8 medium using cluster passaging showed typical, distinct
colony pattern, morphology, and expression of pluripotency markers.
Bright field (BF) images after eight passages. The arrow pointing out
some differentiating cells. Positive expression of pluripotency markers
NANOG, OCT-3/4, SSEA-3, TRA-1-81, and TRA-1-60, and lack of expression
of differentiation marker SSEA-1 after 14 passages in the feeder-free
culture on VTN-N in E8 medium. Counterstaining of nuclei with DAPI.
Scale bars = 200 μm. (TIF 1809 kb)
Additional file 5: Table S1. (DOCX 19 kb)
Additional file 6: Supplementary dataset 1. Optimization of hPSC-RPE
differentiation. (DOCX 36 kb)
Additional file 7: Figure S4. High-quality, functional RPE was derived from
the hiPSC1 line. A) Initial pigmentation rate was not affected by early
neuroectodermal induction as shown in images of pigmented patches after
38 days of differentiation (upper row) with and without initial neuroectodermal
induction (+/– ind.). Neuroectodermal induction increased pigmentation of the
mature hiPSC1-RPE layer after 9 weeks of final culture on inserts, as shown in
DIC confocal images (lower row). Scale bars = 10 μm. B) Similarly, the difference
in pigmentation was reflected in the lower TEER of the highly pigmented RPE
differentiated with induction, while very high TEER was achieved for the less
pigmented cells after spontaneous differentiation; n= 6 inserts. C) RT-PCR
showing signature RPE gene expression and lack of expression of the
pluripotency marker OCT-3/4. D) IF labeling showing RPE protein expression
and localization in vertical confocal sections for the junctional protein ZO-1, the
transporter protein Na+K+-ATPase, and phagocytosis regulator protein tyrosine-
protein kinase Mer (MERTK). E) Confocal sections after 4 h POS feeding at +37 °
C and at +4 °C (negative control). Arrows indicate internalized POS labeled with
anti-opsin antibody. Nuclei counterstained with DAPI; scale bars = 20 μm. F)
Mean PEDF secretion measured with ELISA from the apical side of cell culture
inserts; n=number of inserts. Error bars denote standard deviation. In addition,
the hiPSC1-RPE cells showed normal karyotypes after differentiation with and
without neuroectodermal induction (data not shown). (TIF 18107 kb)
Additional file 8: Supplementary dataset 2. Optimization of hPSC-LESC
differentiation. (DOCX 42 kb)
Additional file 9: Figure S5. Feeder-free hPSCs responded differently
to ectodermal induction compared to hPSCs cultured on feeder cells.
Representative images of hESC1 after corneal differentiation with 10 μM
SB-505124, 10 μM IWP-2, and 50 ng/ml FGF: A) neuronal networks (day
29), B) undesired cell morphology (day 21), and C) massive cell death
(day 14) were observed; scale bars = 100 μm. Relative qPCR analysis of
the early corneal differentiation from D) hFF feeder based culture, and E)
feeder-free culture. Expression levels of undifferentiated hESCs (UD, blue
bars) from the same culture system were used as a calibrator (fold-
change value set to 1) for each gene. Relative fold-change values after
embryoid body formation (EB, red bars) and after 4 or 6 days of induction
(green bars). Error bars denote standard deviation. (TIF 7012 kb)
Additional file 10: Figure S6. Human iPSC-LESCs derived from the
hiPSC2 line showed epithelial morphology and LESC marker expression
at A) day 22 of differentiation, B) day 26 (in total) after cryopreservation
(4 days post-thaw, 112 days frozen), and C) day 34 (in total) after cryo-
preservation and additional replating. Cells showed epithelial morphology
in phase contrast (A) and bright field (BF) images, and expression of LESC
markers PAX6, p40, p63α, cytokeratins 15 (CK15), and 14 (CK14), but no
expression of mature corneal cytokeratins 12 and 3. Scale bars = 100 μm
for all images. (TIF 7742 kb)
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